짧고 검은 머리에 수염을 기른 남성이 파란색 정장 재킷과 흰색 셔츠를 입고 흐릿한 기업 법률 사무실에 서 있는 모습은 시카고 변호사들의 직업적 환경을 반영합니다.

키날 M. 파텔

파트너

키날 M. 파텔

파트너

Kinal Mahesh Patel advises health care, life sciences, and insurance companies on complex transactional, alternative payment model and risk contracting, and regulatory compliance matters. Combining both regulatory and transactional experiences, he delivers legal advice with practical solutions to support clients’ short and long-term goals as they navigate regulatory reforms and industry trends.

Transactional Counsel

Kinal delivers pragmatic deal advice and risk mitigation-oriented solutions to help guide health care providers, plans, and other companies through mergers and acquisitions, joint ventures, and strategic alliances. He has experience with hospital, provider, pharmacy, and health plan acquisitions. He also leads the implementation of partnerships among health care companies and physician and non-physician provider alignment strategies.

Alternative Payment Models and Risk Contracting

Kinal routinely advises clients on alternative payment models and shared-risk arrangements; and on provider network structures, like CINs, ACOs, IPAs, and PHOs, related to compliance with federal and state health care, insurance, and general business laws. He is a sharp negotiator counseling health care providers on managed care and other risk contracting; and provider networks on risk-bearing entity activities, participation agreement design, payor contracting structures, and provider relationship. He supports clients on a variety of payment and service delivery models from CMMI and CMS, including MSSP, BPCI-A, PCF, REACH, GPDC, GUIDE, and other non-governmental risk adjustment models.

규정 준수

Kinal provides regulatory compliance counsel on regulatory, compliance, licensing, and managed care arrangements. He helps clients navigate pending and suspected compliance issues and government enforcement actions, government payor program enrollment and participation requirements, and licensing and accrediting support. He has experience in matters involving fraud and abuse compliance, Medicare and Medicaid reimbursement, corporate compliance programs, health care licensing, and changes of ownership for a variety of providers and suppliers, including health systems, hospitals, physician groups, home health and personal care service providers, home medical equipment suppliers, and device manufacturers.

Kinal is a member of the firm’s Health Care Practice Group; and co-chair of the Health Care & Life Sciences Sector’s Payor Provider Convergence Area of Focus.

대표 경험

  • Counsel to HeartPlace, P.A., the largest physician owned cardiology practice in Texas, in connection with its recapitalization by US Heart & Vascular, an Ares Capital company.
  • Acted as lead counsel in the sale of Houston-based Invicta Health Solutions, LLC, a provider of healthcare revenue cycle management solutions, to RSi, LLC.
  • Counsel to Orthopaedic Institute of Dayton in its recapitalization by Orthopaedic Associates and Revelstoke Capital Partners, LLC.
  • Acted as lead counsel in the sale of Medical Imaging Services, LLC, a company engaged in the distribution, sale, and service of diagnostic imaging equipment, supplies, and parts to 626 Imaging, a Peak Rock Capital portfolio company.
  • Advised University of Florida and UF Health Corporation in the acquisition of the Florida operations of The Scripps Research Institute.
  • Counsel to a middle-market private equity sponsor in the recapitalization of a Medicaid-reimbursed non-medical home health agency opening in Louisiana and Mississippi.
  • Counsel to a middle-market private equity sponsor in the development of a de novo pediatric telemedicine platform in Virginia.
  • Advised an entrepreneurial vascular specialist physician selling physician offices and ambulatory surgery centers and licensing intellectual property to a publicly traded health care organization expanding to a new territory.*
  • Advised on and negotiated an affiliation arrangement between a specialty physician group and a local health system, which initially led to the development of a new cancer center with shared operations. The work enabled the specialty physician group to maintain its independence and meet its growth targets, strengthen its ties with community providers and facilities, and establish the framework to support future strategic opportunities.*
  • Advised a large primary care physician group with a partial recapitalization by a private equity investor and counseled on an establishing a risk-bearing entity structure for limited payor lines. The work involved advice on retaining physician control and ownership, creating alternative profits opportunities in the investor, and establishing an insurance intermediary.*
  • Advised a medical marijuana cultivator, processor, and dispenser combination with a similar enterprise operating in different states with stronger fundraising capabilities. The work involved the transfer of current and future business opportunities under state license applications and provisional licenses.*
  • Advised a DME manufacturer and supplier on private equity recapitalization; a urology group on a sale to a private equity platform; several behavioral health provider practices sale to a private equity platform; a large provider platform’s acquisition of a behavioral health provider practice; and a private fund’s sale of a pet insurance business to a national insurer.*
  • Advised providers and non-providers participating in the Medicare Shared Savings Program and other CMMI payment and service delivery models. This work has involved supporting a participant provider appeal shared savings determinations following a regional rate adjustment that was not reflected in the historical benchmark.*
  • Assisted several ACOs and CINs on governance, financial arrangements, membership, and managed care payor contracting with risk adjustment and shared savings models.
  • Advised a national insurer and PBM and provider-affiliated health plans on Medicare Advantage and Part D compliance, payor disputes, and Medicaid managed care procurements.*
  • Advised a new insurtech firm piloting a managed care product on startup health insurance operations, network development, and population health tools.* The work involved supporting insurance and provider relations teams develop the documentation, processes, and tools to build a network and manage risk while integrating digital innovations and a provider-friendly culture into the traditional provider-insurer relationship.
  • Advised a national insurer on network development for a new pet insurance line.* The work involved developing and negotiating network veterinary clinic arrangements and a corresponding PBM arrangement.
  • Advised hospitals and other providers on billing compliance, licensure, and fraud waste and abuse laws.
  • Advised nationwide substance abuse centers and laboratories on compliance with federal and state fraud and abuse laws, including EKRA.* This work involved working with business and legal teams on staffing, marketing, and partnership arrangements and structures.

* Foley에 합류하기 전에 처리된 사항입니다.

수상 및 표창

  • Recognized, Chambers USA: America’s Leading Lawyers for Business, Healthcare (2024-2025)

제휴

  • American Health Law Association, Transactions Affinity Group, Past vice-chair (2017-2021)
  • Moritz College of Law, The Ohio State University, Former Adjunct professor (2020-2021)
  • Asian Pacific American Bar Association of Central Ohio, Past president and board member (2021)

커뮤니티 참여

  •  Houston Latino Film Festival (Secretary)

프레젠테이션 및 출판물

  • Speaker, “Value-Based Reimbursement and Provider-Initiated Strategies,” Texas Medical Association’s TexMed 2025 Conference (May 10, 2025)
  • Speaker, “Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value,” 2025 National Proton Conference (April 27, 2025)
  • Co-author, “Risk Bearing Entity Requirements: New Jersey and New York,” Health Care Law Today (February 24, 2025)
  • Speaker, “Navigating Reimbursement Realities: Challenges & Opportunities in Value-Based Cancer Care,” CancerX Webinar (February 12, 2025)
  • 공동 저자, "위험 부담 주체 요건: 소개", Health Care Law Today (2024년 11월 18일)
  • Lead Editor, “AHLA Corporate Practice of Medicine: A 50 State Survey,” American Health Law Association (May 2024)
  • Speaker, “Value Based Care Models in Health Care,” Foley Weeks (Dec. 9, 2023)
  • Speaker, “Managed Care Contracting – Key Considerations,” Association of Corporate Counsel (May 2, 2023)
  • Speaker, “What Consents are Required for Hospital Transactions?” American Health Law Association (February 16, 2022)
  • Speaker, “What You Need to Know about Price Transparency and Surprise Billing and How You Should Monitor,” Health Care Compliance Association (December 10, 2021)
2025년 6월 5일 보도 자료

폴리, 챔버스 미국 2025에서 최고 순위 확보

폴리 앤 라드너 LLP는 챔버스 앤 파트너스가 선정한 2025년판 챔버스 USA: 미국 최고의 비즈니스 전문 로펌에 다시 한 번 이름을 올리게 된 것을 자랑스럽게 생각합니다.
May 19, 2025 Health Care Law Today

CMMI’s New Strategic Direction: Trump Administration’s “Make America Healthy Again” Strategy

On May 13th, the Centers for Medicare & Medicaid Services (CMS) Administrator, Dr. Mehmet Oz, and CMS Deputy Administrator and Innovation...
March 25, 2025 In the News

Kinal Patel Assesses Medicare Policy Under Trump Administration

Foley & Lardner LLP partner Kinal Patel commented in the Modern Healthcare article, "Shared Savings Program ACOs wary as CMS halts pay models," describing potential changes to watch as the Trump administration considers Medicare policy.
April 27, 2025 Events

Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value

Foley partner Kinal Patel is speaking at the 2025 National Proton Conference in a panel titled “Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value” on April 27.
May 10, 2025 Events

Value-Based Reimbursement and Provider-Initiated Strategies

Foley partner Kinal Patel will be speaking on the panel “Value-Based Reimbursement and Provider-Initiated Strategies” on May 10 at the Texas Medical Association’s TexMed 2025 Conference.
'메디케어'가 선명하게 보이는 메디케어 카드와 문서를 고정하는 클립을 클로즈업한 이미지로, 기업 법률 사무실이나 민감한 고객 정보를 다루는 시카고의 변호사들 사이에서 자주 볼 수 있는 이미지입니다.
2025년 2월 27일 오늘의 의료법

메디케어 지불 모델 동향 및 경제적 동인 – 트럼프 행정부의 지침을 기다리며

메디케어 프로그램은 의료비 인플레이션 효과와 베이비붐 세대의 고령화 물결 증가로 인한 장기적인 재정적 압박에 계속 직면해 있습니다. 의료비 부담 완화의 대안으로 여겨지는 메디케어 신탁 기금은 오랫동안 재정적 문제라는 고질적인 과제에 직면해 왔습니다.